Status:
COMPLETED
Effects on the Expiratory Flow of AAD in a Critical Patient With IMV
Lead Sponsor:
Parc Taulí Hospital Universitari
Conditions:
Respiratory Physiotherapy
Eligibility:
All Genders
18-100 years
Brief Summary
One of the detrimental effects of invasive mechanical ventilation (IMV) is the alteration of the patient's mucociliary system that requires ventilatory support. The consequence of poor drainage of sec...
Detailed Description
Ventilated air blown into the bronchial shaft through the orotracheal tube (OT) causes ciliary dyskinesia by decreasing the rate of progression of secretions to the proximal pathways. The consequence ...
Eligibility Criteria
Inclusion
- The subjects will be all patients over the age of 18 who are admitted to the ICU of the Parc Taulí University Hospital in Sabadell with IMV requirements
- Subjects with hemodynamic stability; Higher mean blood pressure (PAM) 65 mmg, Heart rate (HR) less than 110 bpm and Oxygen saturation (SpO2) greater than 90% with or without norepinephrine \<0.5 mcg / Kg / min.
Exclusion
- patients with platelet pressures (Pm) greater than 30 cmH2O and / or expiratory pressure at the end of expiration (PEEP) ≥ 10cmH2O
- patients who carriers of thoracic drainage
- patients with costal and / or sternal fractures
- pneumothorax
- pregnant women
- Obesity (BMI\> 35)
- agitated patients with RASS greater than or equal to 3
- patients with intracranial pressures greater than 20 cmH2O
- dying.
Key Trial Info
Start Date :
March 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2024
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT06551636
Start Date
March 1 2022
End Date
April 1 2024
Last Update
August 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitari Parc Taulí
Sabadell, Barcelona, Spain, 08208